Research output: Contribution to journal › Editorial › peer-review
Debbie L Shawcross, Abid Suddle
| Original language | English |
|---|---|
| Journal | Liver Transplantation |
| Early online date | 27 Nov 2021 |
| DOIs | |
| Accepted/In press | 2021 |
| E-pub ahead of print | 27 Nov 2021 |
| Additional links |
Statins: a panacea to reduce_SHAWCROSS_Publishedonline27November2021_GREEN AAM
Statins_a_panacea_to_reduce_SHAWCROSS_Publishedonline27November2021_GREEN_AAM.pdf, 1.73 MB, application/pdf
Uploaded date:02 Dec 2021
Version:Accepted author manuscript
In Greek mythology Panacea was the goddess of universal remedy or health. In literary terms a panacea represents a solution to solve all ills and there are few drugs that can claim such an accolade. One drug class that has claimed to be a panacea in adults at increased risk of cardiovascular disease are statins. Since their FDA approval in the late 1980s, statins have revolutionised the management of hypercholesterolemia.
King's College London - Homepage
© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454